Not applicableEnrolling By InvitationNCT07159087
What this trial is testing
The Safety and Efficacy for In-segment Late Lumen Loss of the 'Genoss® SCB' Versus 'SeQuent® Please NEO' in Patients With Coronary ISR
Who this might be right for
Coronary Arterial Disease (CAD)
Genoss Co., Ltd. 94